Products billed under this code include Fluad Trivalent (2025/2026) (Preservative Free).
Payment limit per 0.5 ML, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Fluad Trivalent (2025/2026) (Preservative Free) | Seqirus Inc | 70461-0025-03 | 10 | $1,225.22 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $122.522 | +$24.362 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted September 17, 2026 |
| 3Q26 | $98.16 | $0.00 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted September 15, 2026 |
| 2Q26 | $98.16 | $0.00 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted September 15, 2026 |
| 1Q26 | $98.16 | $0.00 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted September 15, 2026 |
| 4Q25 | $98.16 | +$14.67 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted September 8, 2026 |
| 3Q25 | $83.49 | $0.00 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted March 10, 2026 |
| 2Q25 | $83.49 | $0.00 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted March 10, 2026 |
| 1Q25 | $83.49 | $0.00 | 0.5 ML | Iiv adjuvant vaccine im | v1, posted December 19, 2025 |
| 4Q24 | $83.49 | – | 0.5 ML | Iiv adjuvant vaccine im | v1, posted June 11, 2025 |
| 3Q21 | $59.529 | $0.00 | 0.5 ml | Iiv adjuvant vaccine im | v1, posted June 2, 2022 |
| 2Q21 | $59.529 | $0.00 | 0.5 ml | Iiv adjuvant vaccine im | v1, posted March 1, 2022 |
| 1Q21 | $59.529 | – | 0.5 ml | Iiv adjuvant vaccine im | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
